Annual Current Liabilities
$47.73 M
-$63.98 M-57.27%
31 December 2023
Summary:
Sangamo Therapeutics annual total current liabilities is currently $47.73 million, with the most recent change of -$63.98 million (-57.27%) on 31 December 2023. During the last 3 years, it has fallen by -$95.82 million (-66.75%). SGMO annual current liabilities is now -66.75% below its all-time high of $143.55 million, reached on 31 December 2020.SGMO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$43.16 M
+$4.16 M+10.66%
30 September 2024
Summary:
Sangamo Therapeutics quarterly total current liabilities is currently $43.16 million, with the most recent change of +$4.16 million (+10.66%) on 30 September 2024. Over the past year, it has dropped by -$5.32 million (-10.98%). SGMO quarterly current liabilities is now -69.93% below its all-time high of $143.55 million, reached on 31 December 2020.SGMO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGMO Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -57.3% | -11.0% |
| 3 y3 years | -66.8% | -67.3% |
| 5 y5 years | -39.2% | -46.4% |
SGMO Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -66.8% | at low | -67.3% | +10.7% |
| 5 y | 5 years | -66.8% | at low | -69.9% | +10.7% |
| alltime | all time | -66.8% | +4673.1% | -69.9% | +4617.1% |
Sangamo Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $43.16 M(+10.7%) |
| June 2024 | - | $39.01 M(-3.1%) |
| Mar 2024 | - | $40.24 M(-15.7%) |
| Dec 2023 | $47.73 M(-57.3%) | $47.73 M(-1.5%) |
| Sept 2023 | - | $48.48 M(-9.9%) |
| June 2023 | - | $53.79 M(-7.0%) |
| Mar 2023 | - | $57.84 M(-48.2%) |
| Dec 2022 | $111.71 M(-12.6%) | $111.71 M(-8.7%) |
| Sept 2022 | - | $122.36 M(+2.0%) |
| June 2022 | - | $119.99 M(+1.2%) |
| Mar 2022 | - | $118.53 M(-7.3%) |
| Dec 2021 | $127.89 M(-10.9%) | $127.89 M(-3.0%) |
| Sept 2021 | - | $131.90 M(-3.7%) |
| June 2021 | - | $136.94 M(+3.1%) |
| Mar 2021 | - | $132.84 M(-7.5%) |
| Dec 2020 | $143.55 M(+105.4%) | $143.55 M(+16.2%) |
| Sept 2020 | - | $123.56 M(+31.5%) |
| June 2020 | - | $93.94 M(+51.4%) |
| Mar 2020 | - | $62.06 M(-11.2%) |
| Dec 2019 | $69.87 M(-11.0%) | $69.87 M(-13.3%) |
| Sept 2019 | - | $80.55 M(-1.8%) |
| June 2019 | - | $82.05 M(-10.0%) |
| Mar 2019 | - | $91.13 M(+16.1%) |
| Dec 2018 | $78.51 M(+75.0%) | $78.51 M(+5.9%) |
| Sept 2018 | - | $74.12 M(-2.4%) |
| June 2018 | - | $75.95 M(+53.8%) |
| Mar 2018 | - | $49.39 M(+10.1%) |
| Dec 2017 | $44.86 M(+237.5%) | $44.86 M(+4.5%) |
| Sept 2017 | - | $42.94 M(+3.1%) |
| June 2017 | - | $41.66 M(+218.9%) |
| Mar 2017 | - | $13.06 M(-1.7%) |
| Dec 2016 | $13.29 M(-33.9%) | $13.29 M(-4.2%) |
| Sept 2016 | - | $13.87 M(-4.1%) |
| June 2016 | - | $14.46 M(+43.3%) |
| Mar 2016 | - | $10.09 M(-49.8%) |
| Dec 2015 | $20.10 M(-3.8%) | $20.10 M(-9.2%) |
| Sept 2015 | - | $22.13 M(+5.1%) |
| June 2015 | - | $21.06 M(+5.4%) |
| Mar 2015 | - | $19.97 M(-4.4%) |
| Dec 2014 | $20.88 M(+106.1%) | $20.88 M(+7.1%) |
| Sept 2014 | - | $19.49 M(+16.0%) |
| June 2014 | - | $16.80 M(+2.4%) |
| Mar 2014 | - | $16.41 M(+61.9%) |
| Dec 2013 | $10.13 M(+15.3%) | $10.13 M(+44.6%) |
| Sept 2013 | - | $7.00 M(-0.7%) |
| June 2013 | - | $7.05 M(+18.5%) |
| Mar 2013 | - | $5.95 M(-32.3%) |
| Dec 2012 | $8.79 M | $8.79 M(+46.0%) |
| Sept 2012 | - | $6.02 M(-2.1%) |
| June 2012 | - | $6.15 M(+9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $5.61 M(-22.1%) |
| Dec 2011 | $7.20 M(+1.6%) | $7.20 M(+73.8%) |
| Sept 2011 | - | $4.14 M(+3.4%) |
| June 2011 | - | $4.01 M(+18.7%) |
| Mar 2011 | - | $3.38 M(-52.4%) |
| Dec 2010 | $7.09 M(-54.7%) | $7.09 M(+66.9%) |
| Sept 2010 | - | $4.25 M(+16.9%) |
| June 2010 | - | $3.64 M(-61.1%) |
| Mar 2010 | - | $9.34 M(-40.3%) |
| Dec 2009 | $15.66 M(+34.6%) | $15.66 M(+125.8%) |
| Sept 2009 | - | $6.93 M(-10.0%) |
| June 2009 | - | $7.71 M(-26.6%) |
| Mar 2009 | - | $10.50 M(-9.7%) |
| Dec 2008 | $11.63 M(+20.1%) | $11.63 M(-14.3%) |
| Sept 2008 | - | $13.58 M(+8.4%) |
| June 2008 | - | $12.52 M(+45.8%) |
| Mar 2008 | - | $8.58 M(-11.3%) |
| Dec 2007 | $9.68 M(+86.2%) | $9.68 M(+20.3%) |
| Sept 2007 | - | $8.04 M(+28.2%) |
| June 2007 | - | $6.27 M(+29.6%) |
| Mar 2007 | - | $4.84 M(-6.9%) |
| Dec 2006 | $5.20 M(-23.5%) | $5.20 M(+6.9%) |
| Sept 2006 | - | $4.86 M(+7.2%) |
| June 2006 | - | $4.54 M(-4.0%) |
| Mar 2006 | - | $4.72 M(-30.5%) |
| Dec 2005 | $6.79 M(+189.4%) | $6.79 M(+208.1%) |
| Sept 2005 | - | $2.21 M(+55.7%) |
| June 2005 | - | $1.42 M(-19.7%) |
| Mar 2005 | - | $1.76 M(-24.9%) |
| Dec 2004 | $2.35 M(+49.5%) | $2.35 M(+69.0%) |
| Sept 2004 | - | $1.39 M(+33.2%) |
| June 2004 | - | $1.04 M(+14.0%) |
| Mar 2004 | - | $915.00 K(-41.8%) |
| Dec 2003 | $1.57 M(-20.7%) | $1.57 M(-27.4%) |
| Sept 2003 | - | $2.16 M(+24.7%) |
| June 2003 | - | $1.74 M(+35.7%) |
| Mar 2003 | - | $1.28 M(-35.4%) |
| Dec 2002 | $1.98 M(-25.7%) | $1.98 M(+35.1%) |
| Sept 2002 | - | $1.47 M(-5.5%) |
| June 2002 | - | $1.55 M(-23.6%) |
| Mar 2002 | - | $2.03 M(-23.9%) |
| Dec 2001 | $2.67 M(+31.1%) | $2.67 M(+24.2%) |
| Sept 2001 | - | $2.15 M(+90.1%) |
| June 2001 | - | $1.13 M(-45.8%) |
| Mar 2001 | - | $2.08 M(+2.4%) |
| Dec 2000 | $2.04 M(+103.5%) | $2.04 M(+121.0%) |
| Sept 2000 | - | $921.00 K(-14.5%) |
| June 2000 | - | $1.08 M(-26.8%) |
| Mar 2000 | - | $1.47 M |
| Dec 1999 | $1.00 M | - |
FAQ
- What is Sangamo Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Sangamo Therapeutics?
- What is Sangamo Therapeutics annual current liabilities year-on-year change?
- What is Sangamo Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Sangamo Therapeutics?
- What is Sangamo Therapeutics quarterly current liabilities year-on-year change?
What is Sangamo Therapeutics annual total current liabilities?
The current annual current liabilities of SGMO is $47.73 M
What is the all time high annual current liabilities for Sangamo Therapeutics?
Sangamo Therapeutics all-time high annual total current liabilities is $143.55 M
What is Sangamo Therapeutics annual current liabilities year-on-year change?
Over the past year, SGMO annual total current liabilities has changed by -$63.98 M (-57.27%)
What is Sangamo Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of SGMO is $43.16 M
What is the all time high quarterly current liabilities for Sangamo Therapeutics?
Sangamo Therapeutics all-time high quarterly total current liabilities is $143.55 M
What is Sangamo Therapeutics quarterly current liabilities year-on-year change?
Over the past year, SGMO quarterly total current liabilities has changed by -$5.32 M (-10.98%)